Shire Share Discussion Threads

[montyhedge] 20/4/2018 13:54

Good article in The Guardian, Shire fell to 30 pounds over worries on its debt. Takeda would have to leverage to acquire Shire, so levering up to more leverage debt. What's the attraction holding Takeda shares.Good point.

[montyhedge] 20/4/2018 13:35

Takeda shares who wants them?

[philanderer] 20/4/2018 13:13

Plenty of Shire stuff on Alphaville this morning..

[steeplejack] 20/4/2018 11:40

And you won't be alone in not wanting Takeda shares.Even the institutions will find a transference of a holding in Shire to Takeda as being tiresome and that's despite a US listing as well as Japanese.In any event,I think it unlikely that Shire will recommend the bid unless it exceeds 48 perhaps 50 pounds....can Takeda go that high without seeing its price weakening.The reason I'm staying in is because another predator might emerge.

[hortensius] 20/4/2018 10:52

wouldn't be surprised if we recieved another offer with a better cash/share split before the deadline still don't see it being accepted though

[montyhedge] 20/4/2018 10:39

Who wants Takeda shares, I think they would be hard to sell. Cash element waste of space.

[montyhedge] 20/4/2018 10:36

Only problem with Shire compared to GSK, hardly a dividend yield here.

[suffersnofools] 20/4/2018 10:27

Inki - trueHowever, the fact the share price falls back so markedly when likelihood of a bid recedes will put Board under immense pressure with major holders. The market is basically saying the only way to get fair value is through a bid.

[ny boy] 20/4/2018 10:26

Plenty of action to coming adding on this pull back.

I have also been adding to my long term (GSK) holdings, can’t be long before they become a big target, especially at depressed values. The whole sector could do with a huge acquisition, it’s coming, the climate is right.

[inki] 20/4/2018 10:18

Shire directors do not want to be acquired. They loose their autonomy and the CEO has already shown contempt for the shareholders before in his comments.

[montyhedge] 20/4/2018 10:08

Takeda can't afford it £17 in cash no good, also end up with Takeda shares I think hard to deal in as everyone tries to exit.

[swedeee] 20/4/2018 09:58

agree with suffersnfools. the BoD know how much shire is worth regardless of the share price they know that any bidder is getting a great deal

[philanderer] 20/4/2018 09:48

"Shire Rebuff May Not Dim Takeda's Appetite for a Takeover"


There’s a good chance Takeda could come back with another offer, and in order to make it more appealing to Shire shareholders it may have to boost the cash portion of its bid, said Credit Suisse Group analyst Fumiyoshi Sakai. Still, Sakai said the financing appeared to be up in the air and Weber’s credibility with investors is on the line.

“If he makes the decision to go for it, he’s going to have to see it through,” Sakai said.

A Takeda spokeswoman declined to comment.


full article link:

[suffersnofools] 20/4/2018 09:43

paa65 = The BoD obviously have a price they think the buisness is worth. That won't be impacted by the prevailing market price.

[paa65] 20/4/2018 09:39

Could Allergan be playing a smart game here?Avoid the bidding war. Let Takeda make a last bid (probably rejected again).See SHP share price fall again.And then come in with a better cash offer?

[scothernman] 20/4/2018 09:25

Can those with experience please enlighten us what happens for example if the revised bid is for £50 and £20 is paid in cash and £30 in takeda shares, if one holds 1000 shares of SHP currently. 1. What may the marketmakers value SHP in such a scenario as it is not all cash I
i.e., share price next Friday? 2. if takeda shares value drops further what may be the true value (educated guess) of SHP after takeover. 3. How long it may take for takeda to list on UK stock exchange to sell the new shares you have acquired? Thanks for your replies.

[philanderer] 20/4/2018 08:51

Taken out a small short to protect some capital in case it all collapses back to 3000p if nothing materialises by next wednesday.

Morning guys.

[broadwood] 20/4/2018 08:48

US pharma giant Allergan has pulled back from tabling a bid for UK-listed rival Shire just hours after first indicating its possible interest.
Invoking requirements under the UK Takeover Code, the Dublin-based outfit said it did not intend to make an offer, adding that it was continuing to examine the "full range" of strategic options at its disposal, including divestitures, combinations and acquisitions.


Initial reports that it might wade into the fray for Shire, earlier in the session, had seen the company's share price dive by just under 9%.
As of 2047 BST they had trimmed their initial fall to trade down by 4.48% to $158.16.

[billytkid2] 20/4/2018 08:44

Problem is it won't be 4650. Given it is over 60% in Takeda shares and they will likely tank further after confirmation the result is a lot lower offer.

[demo trader] 20/4/2018 08:01

OPENS 150P LOWER

[demo trader] 20/4/2018 07:58

Offer of 4650p is good enough, obviously not for few. Better than recent low of 3000p

[suffersnofools] 20/4/2018 07:40

There's enough interest flying around to make it a good traders toy in the range 3700-4200 for now.

[bubloo] 20/4/2018 07:38

it will taken out with a slightly improved cash component